Cite
HARVARD Citation
Khanna, D. et al. (n.d.). FRI0268 Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from The Open-Label Period of The Fasscinate Trial. Annals of the rheumatic diseases. pp. 531-532. [Online].